We are live on ! Find out more
DMKJ

David M. Knott Jr Portfolio holdings

AUM $168M
1-Year Est. Return 60.36%
This Fund
S&P 500
This Quarter Est. Return
+3.86%
1 Year Est. Return
+60.36%
3 Year Est. Return
+143.93%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$238M
AUM Growth
-$511K
Cap. Flow
-$4.31M
Cap. Flow %
-1.81%
Top 10 Hldgs %
56.07%
Holding
204
New
16
Increased
9
Reduced
10
Closed
19

Top Buys

1
CDXS icon
Codexis
CDXS
+$1.79M
2
GSK icon
GSK
GSK
+$1.52M
3
FIP icon
FTAI Infrastructure
FIP
+$1.21M
4
FSTX
F-star Therapeutics, Inc. Common Stock
FSTX
+$1.01M
5
AVDL
Avadel Pharmaceuticals
AVDL
+$920K

Top Sells

1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$3.65M
2
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
+$3.07M
3
INCY icon
Incyte
INCY
+$2.04M
4
INVA icon
Innoviva
INVA
+$1.7M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$1.48M

Sector Composition

1 Healthcare 32.49%
2 Materials 25.45%
3 Financials 10.86%
4 Real Estate 6.17%
5 Communication Services 4.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AVDL
26
DELISTED
Avadel Pharmaceuticals
AVDL
$1.96M 0.82%
390,861
+167,081
+75% +$920K
CHRS icon
27
Coherus Oncology
CHRS
$216M
$1.92M 0.81%
200,000
+13,866
+7% +$140K
TWLVW
28
DELISTED
Twelve Seas Investment Company II Warrant
TWLVW
$1.92M 0.81%
166,666
– –
EXE
29
Expand Energy Corp
EXE
$21.1B
$1.88M 0.79%
20,000
– –
RHP icon
30
Ryman Hospitality Properties
RHP
$7.99B
$1.8M 0.76%
24,400
– –
AB icon
31
AllianceBernstein
AB
$3.54B
$1.77M 0.75%
50,500
– –
MOS icon
32
The Mosaic Company
MOS
$7.03B
$1.69M 0.71%
35,000
– –
BIP icon
33
Brookfield Infrastructure Partners
BIP
$18.1B
$1.62M 0.68%
45,000
– –
OVV icon
34
Ovintiv
OVV
$16.2B
$1.61M 0.68%
35,000
– –
KAIRW
35
DELISTED
Kairos Acquisition Corp. Warrant
KAIRW
$1.6M 0.67%
139,278
– –
TECK icon
36
Teck Resources
TECK
$27B
$1.52M 0.64%
50,000
– –
CLMT icon
37
CALL
Calumet Specialty Products
CLMT
$3.73B
$1.47M 0.62%
+115,000
New +$1.65M
CVE icon
38
Cenovus Energy
CVE
$52.1B
$1.46M 0.61%
95,000
– –
BBIO icon
39
BridgeBio Pharma
BBIO
$15.9B
$1.42M 0.6%
143,096
-70,110
-33% -$728K
CDXS icon
40
Codexis
CDXS
$204M
$1.35M 0.57%
+222,107
New +$1.79M
BRIVW
41
DELISTED
B. Riley Principal 250 Merger Corp. Warrant
BRIVW
$1.34M 0.56%
116,666
– –
FSTX
42
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$1.21M 0.51%
235,945
+160,491
+213% +$1.01M
GSK icon
43
GSK
GSK
$104B
$1.18M 0.5%
+40,000
New +$1.52M
PMGMW
44
DELISTED
Priveterra Acquisition Corp. II Warrant to purchase Class A common stock
PMGMW
$1.15M 0.48%
100,000
– –
GMED icon
45
Globus Medical
GMED
$10.5B
$1.12M 0.47%
18,831
– –
INCY icon
46
Incyte
INCY
$23.4B
$1.08M 0.46%
16,257
-27,563
-63% -$2.04M
FIP icon
47
FTAI Infrastructure
FIP
$492M
$1.02M 0.43%
+425,000
New +$1.21M
WPC icon
48
W.P. Carey
WPC
$16.9B
$838K 0.35%
12,252
– –
LOKM.WS
49
DELISTED
Live Oak Mobility Acquisition Corp. Warrants, exercisable for one share of Class A common stock at an exercise price of $11.50 per share
LOKM.WS
$828K 0.35%
72,030
– –
VKTX icon
50
Viking Therapeutics
VKTX
$4.31B
$821K 0.35%
301,803
+35,000
+13% +$115K
1
2
3 4 5

Similar funds

DI
Disciplined Investors Waco, Texas $168M AUM 23.6% 1-Year Est. Return
WFS
Widmann Financial Services Bowie, Maryland $168M AUM 24.36% 1-Year Est. Return
CCG
Catalina Capital Group Torrance, California $168M AUM 16.69% 1-Year Est. Return
7CM
7G Capital Management New York $168M AUM 45.68% 1-Year Est. Return
TT
TI-Trust Quincy, Illinois $168M AUM 24.32% 1-Year Est. Return
MAG
Meadowbrook Advisors Group Bedminster, New Jersey $168M AUM
PFA
Presper Financial Architects Akron, Ohio $168M AUM 12.94% 1-Year Est. Return
CW
Code Waechter Tampa, Florida $168M AUM 15.56% 1-Year Est. Return

David M. Knott Jr's Q3 2022 Portfolio in Review

As of Q3 2022, David M. Knott Jr held 204 positions worth $238M, down 0.21% from $238M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

David M. Knott Jr's Q3 2022 filing shows 16 new, 9 increased, 10 reduced and 19 closed positions. Its largest new stake was Codexis: 222,107 shares worth $1.35M. The largest sale was Biohaven Pharmaceutical Holding Company Ltd., an estimated $3.65M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 34% a quarter earlier, followed by Materials and Financials.

  • David M. Knott Jr's largest Q3 2022 buy was Codexis: 222,107 shares worth $1.35M.
  • David M. Knott Jr added most to F-star Therapeutics, Inc. Common Stock in Q3 2022, an estimated $1.01M increase.
  • David M. Knott Jr's biggest Q3 2022 reduction was Incyte, cutting an estimated $2.04M.
  • David M. Knott Jr fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q3 2022, selling an estimated $3.65M.
  • David M. Knott Jr's ten largest holdings make up 56% of its $238M portfolio in Q3 2022.
  • David M. Knott Jr opened 16 new positions and closed 19 in Q3 2022.
  • David M. Knott Jr's portfolio value fell 0.21% quarter-over-quarter to $238M.

Based on David M. Knott Jr's 13F filing for Q3 2022, filed 10 Nov 2022.